Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
The relations between the single high affinity binding sites for azapropazone, phenylbutazone, chlorpropamide, sulfathiazole, and iophenoxate and the binding regions of human serum albumin represented by the marker ligands diazepam, phenol red, salicylate, and warfarin were examined by a series of competition experiments. Binding was determined by equilibrium dialysis at pH 7.0. In order to ensure an accurate analysis of the competition experiment, the number of moles of ligand bound per mole of protein was usually 0.4 or less to minimize ligand binding to weaker sites. Furthermore, binding of both ligands was determined in all experiments (except for iophenozate). None of the test ligands competed with diazepam for a common high affinity binding site, but, surprisingly, they were all able to displace two or three of the other marker ligands according to a competitive scheme. These findings show, first, the existence of a particular serum albumin region for high affinity binding of diazepam. Secondly, they imply that it is not necessary to assume the existence of new drug binding regions beyond those existing for phenol red, salicylate, and warfarin. On the contrary, the relatively many examples of competitive binding indicate that the binding regions represented by the last-mentioned three marker ligands are placed quite close to each other in the albumin molecule in a common region, which is suggested to be located at subdomains 1C and 2A-B. The region must be relatively large, because in some cases independent high affinity binding of pairs of ligands is observed. It is probably also rather flexible, inasmuch as no clear relation could be found between the chemical structure of the test ligands and the two or three marker ligands with which they compete. Correlations between primary association constants and partition coefficients for both marker ligands and test ligands, in the unionized forms, between n-hexane or 1-octanol and aqueous media showed that hydrophobic forces are important for the binding processes. However, the data also showed that other attractive forces must be operative as well.
Kragh-Hansen
U
U
Institute of Medical Biochemistry, University of Aarhus, Denmark.
D001032:Apazone / Q000378:metabolism; D001665:Binding Sites; D001667:Binding, Competitive; D002747:Chlorpropamide / Q000378:metabolism; D003975:Diazepam / Q000378:metabolism; D006801:Humans; D007480:Iopanoic Acid / Q000031:analogs & derivatives / Q000378:metabolism; D007700:Kinetics; D008024:Ligands; D010653:Phenylbutazone / Q000378:metabolism; D011485:Protein Binding; D012459:Salicylates / Q000378:metabolism*; D020156:Salicylic Acid; D012709:Serum Albumin / Q000378:metabolism*; D000077589:Sulfathiazole; D013432:Sulfathiazoles / Q000378:metabolism; D014859:Warfarin / Q000378:metabolism*
D008024:Ligands; D012459:Salicylates; D012709:Serum Albumin; D013432:Sulfathiazoles; D014859:Warfarin; C008160:iophenoxic acid; D007480:Iopanoic Acid; D010653:Phenylbutazone; D001032:Apazone; D020156:Salicylic Acid; D003975:Diazepam; D002747:Chlorpropamide; D000077589:Sulfathiazole